Enhanced Antibacterial Ability and Bioactivity of Polyetherketoneketone Modified with LL-37.
Jin. Yabing Y; Wang. Yijin Y; Chen. Yuhong Y; Han. Tianlei T; Chen. Yiyi Y; Wang. Chen C
Key Findings
- LL‑37 can be stably bonded to PEKK via a polydopamine layer and released for >6 days
- The LL‑37‑coated PEKK dramatically reduced Staphylococcus aureus and Escherichia coli adhesion and biofilm formation
- The modified surface improved human stem cell adhesion, viability, and osteogenic differentiation
Practical Outcomes
- For everyday biohackers there’s no direct way to use this finding, but it hints that future orthopedic implants might be less infection‑prone and promote bone healing. It’s mainly relevant for medical device developers rather than personal health regimens.
Summary
Scientists attached the natural antimicrobial peptide LL‑37 to a plastic material used for bone implants (PEKK). The coating slowly released the peptide for about a week, cutting down bacterial growth and helping stem cells stick and turn into bone cells. This shows the material could be safer for surgeries, but it doesn’t give a DIY health protocol.
Abstract
Polyetherketoneketone (PEKK) is considered to be a potential substitute material for metal bone implants because of its advantageous biocompatibility, chemical stability, and mechanical properties, but clinical application has been severely restricted due to PEKK's lack of antibacterial ability and biological activity. In this study, LL-37, a natural human antimicrobial peptide, was successfully modified on the PEKK surface with polydopamine as the intermediate layer and released continuously for more than 6 days. The results of the MTT assay, colony counts, and Live/Dead staining demonstrated that compared to unmodified PEKK, the LL-37-modified PEKK significantly inhibited the adhesion, vitality, and bacterial biofilm growth of <i>Staphylococcus aureus</i> and <i>Escherichia coli</i> in a concentration-dependent way. Furthermore, the LL-37-modified PEKK enhanced biocompatibility (cell adhesion and viability) and promoted osteogenic differentiation of human umbilical cord Wharton's jelly-derived mesenchymal stem cells. Our data suggested that LL-37-modified PEKK might be a promising material for use in orthopedic implants.
Study Information
pubmed
2022
2022-04-05T00:00:00.000Z
10.1021/acs.langmuir.1c03319
10
49